Conformis Inc: Rises after U.S. FDA approves knee replacement system
** Shares of medical device maker Conformis Inc CFMS.O up
7.3% at 90 cents
** Co says U.S. FDA approves its knee replacement system,
Identity Imprint
** The new knee replacement system combines implant sizes
with standard and patient-specific surgical instruments - CFMS
** Company says it will be able to provide a patient-matched
Identity Imprint system in 3 weeks versus the six weeks lead
time for its earlier older knee replacement system, iTotal
Identity
** CFMS is up ~37% YTD
(Reporting by Dania Nadeem in Bengaluru)
((Dania.Nadeem@thomsonreuters.com;))
Recent news on ConforMIS
See all newsBrief: Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Conformis Stockholders Vote “For” The Pending Merger With Restored
Brief: Proxy Advisory Firm Iss Recommends Conformis Stockholders Vote “For” The Pending Merger With Restor3d
Conformis Inc reports results for the quarter ended in June - Earnings Summary
U.S. RESEARCH ROUNDUP- Booking Holdings, Monster Beverage, Topbuild
U.S. STOCKS ON THE MOVE-Graphite Bio, Leggett & Platt, Nauticus Robotics